Recalling the universal health coverage vision and equity in the COVID-19 vaccine distribution plan


Posted: 2021-10-04 19:00:00
Pan Afr Med J . 2021 Jul 13;39:197. doi: 10.11604/pamj.2021.39.197.29041. eCollection 2021. Affiliations Expand Affiliations 1 Department of Business Law, Faculty of Law, Obafemi Awolowo University, Ile-Ife, Nigeria. 2 Department of Internal Medicine, Faculty of Clinical Sciences, University of Medical Sciences, Ondo, Nigeria. Item in Clipboard Oludamilola Adebola Adejumo et al. Pan Afr Med J. 2021. Show details Display options Display options Format Pan Afr Med J . 2021 Jul 13;39:197. doi: 10.11604/pamj.2021.39.197.29041. eCollection 2021. Affiliations 1 Department of Business Law, Faculty of Law, Obafemi Awolowo University, Ile-Ife, Nigeria. 2 Department of Internal Medicine, Faculty of Clinical Sciences, University of Medical Sciences, Ondo, Nigeria. Item in Clipboard CiteDisplay options Display options Format Abstract The COVID-19 pandemic has changed the world in so many ways since 2019 when the first case was recorded. COVID-19 pandemic has impacted negatively on economy, health, education and infrastructure globally. COVID-19 vaccine was developed with the aim of stopping the pandemic and allowing the rebuilding of our societies and economies. The vaccine was rolled out in December 2020 and the distribution plan appears to be skewed in favour of high income countries. This paper highlights the need for consideration of the principles of equity and universal health coverage in the distribution plan of the vaccine. It emphasizes the need to ensure that the interests of citizens of developing and low income countries are well protected. The paper concludes that issues of disparity in economic status of countries entering agreement with the vaccine manufacturing companies, absence of logistic support among others should not be a barrier to ensuring equitable access to vaccine for all consistent with the sustainable development goal 3.7. Keywords: COVID-19; Universal basic coverage; equity; vaccine. Copyright: Oludamilola Adebola Adejumo et al. Conflict of interest statement The authors declare no competing interests. [x] Cite Copy Format: Send To [x]

参考サイト PubMed: covid-19



バイオクイックニュース日本語版:COVID-19特集

バイオクイックニュース日本語版
7月 10, 2020 バイオアソシエイツ

血液型とCOVID-19の重篤化リスクについての関連性がNEJMで発表

2020年6月18日、NIHのディレクターであるFrancis Collins 医学博士は、血液型と重度の COVID-19 のリスクについてブログに投稿した。 本記事は、そのブログの内容に基づいている 。 Collins 博士のブログのタイトルは「遺伝子、血液型は深刻なCOVID-19のリスクに結びついている(Genes, Blood Type Tied to Risk of Severe COVID-19.)」…

ゲスト 890人 と メンバー 7人 がオンラインです